(Q61853646)
Statements
A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis (English)
Eiko Toichi
Bart Frederick
Mary Ann Mascelli
Alice B Gottlieb
Daniel E Everitt
Charles E Pendley
Martin A Graham